Baotou Tianhe Magnetics Technology
603072
HuangShan Googe
301581
Geovis Insighter Technology
920116
CHICHENG ELECTRIC
834407
Xdc Industries(Shenzhen)Limited
300615
CN Stock MarketDetailed Quotes
002100 Tecon Biology Co.Ltd
- 6.25
- -0.19-2.95%
Market Closed Jan 3 15:00 CST
8.53BMarket Cap-29.07P/E (TTM)
6.49High6.22Low316.83KlotVolume6.45Open6.44Pre Close201.10MTurnover2.32%Turnover RatioLossP/E (Static)1.37BShares8.8752wk High1.23P/B8.53BFloat Cap5.6752wk Low7.08Limit Up1.37BShs Float19.02Historical High5.80Limit Down4.19%Amplitude-0.32Historical Low--Dividend TTM6.35Avg Price187.95KlotAsk--Div YieldTTM100Lot Size125.38KlotBid
Tecon Biology Co.Ltd News
Tiankang Biotech: Announcement on the progress of the controlling shareholder\'s increase in the company\'s shares
Tiankang Biotech: Announcement on the controlling shareholder increasing the company\'s shares to 1%
Tiankang Biotech: Announcement on the progress of the controlling shareholder increasing the company\'s shares for the first time
Tiankang Biotech: Announcement on the controlling shareholder\'s plan to increase the company\'s share holdings and receiving loan support to increase capital holdings
Tecon Biology Co.Ltd: Announcement on the 2023 Profit Distribution Plan
Tiankang Biotech: Announcement on the completion of the controlling shareholder\'s plan to increase the company\'s shares
Tiankang Biotech: Announcement on the progress of the controlling shareholder\'s plan to increase the company\'s shares by half of the time
Tiankang Biotech: 2022 Annual Equity Distribution Implementation Notice
Tiankang Biotech: Announcement on Tiankang debt-to-share price adjustments
Tiankang Biotech: CITIC Construction Investment Securities Co., Ltd.\'s Sponsorship Summary Report on Tiankang Biotech\'s Non-public Offering of Shares
Tiankang Biotech: Announcement on the extension of the plan of the controlling shareholder, Xinjiang Production and Construction Corps State-owned Assets Management Co., Ltd., to increase the company\'s shares
Tiankang Biotech: Announcement on the Settlement of Some Non-public Stock Fundraising Projects and Permanently Supplementing Liquidity with Savings Raised
Tiankang Biotech: CITIC Construction Investment Securities Co., Ltd.\'s inspection opinion on the conclusion of Tiankang Biotech\'s non-public stock fundraising project and permanently replenishing working capital from savings raised
Tiankang Biotech: Announcement on 2022 Profit Distribution Plan
Tiankang Biotech: Notice on Unfreezing Company Shares Held by Shareholders Holding 5% or More
Tiankang Biotech: Announcement on the progress of the controlling shareholder's plan to increase the company's shares by half of the time
Tiankang Biotech: Announcement on the controlling shareholder's increase in the company's shares and subsequent plans to increase its holdings
Tiankang Biotech: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2022
Tiankang Biotech: Announcement on the completion of non-trading transfers of employees' stock ownership plan shares to holders' stock accounts
Tiankang Biotech: Announcement on the conversion of convertible corporate bonds to shares in the second quarter of 2022
